Clinical usefulness of D2-40 in non-small cell lung cancer

Lung

Volumn 189, Issue 1, 2011, Pages 57-63

  Min, Kyung Hoon ^a   Park, Seoung Ju ^a   Lee, Kyung Sun ^a   Hwang, Sung Ho ^a   Kim, So Ri ^a   Moon, Hee ^a   Han, Hyo Jin ^a   Chung, Myoung Ja ^a   Lee, Yong Chul ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

D2 40; Lymphangiogenesis; Lymphatic metastasis; Lymphatic vessels; Non small cell lung cancer

Indexed keywords

MONOCLONAL ANTIBODY D2-40;

ADENOCARCINOMA; ARTICLE; CANCER INVASION; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SIALOGLYCOPROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952281613     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-010-9268-x     Document Type: Article

References (40)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. K Suzuki K Nagai J Yoshida M Nishimura K Takahashi T Yokose Y Nishiwaki 1999 Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses Cancer 86 1976 1984 1:STN:280:DC%2BD3c%2FktVWisA%3D%3D 10.1002/(SICI)1097-0142(19991115)86: 10<1976::AID-CNCR14>3.0.CO;2-I 10570421
3. PA Bunn Jr 2004 Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy Clin Lung Cancer 6 85 98 1:CAS:528:DC%2BD2cXpvFOjsb8%3D 10.3816/CLC.2004.n.022 15476594 (Pubitemid 39440206)
4. M Okada W Nishio T Sakamoto H Harada K Uchino N Tsubota 2003 Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma J Thorac Cardiovasc Surg 126 558 562 10.1016/S0022-5223(03)00360-X 12928658 (Pubitemid 37048526)
5. SM Lee 2006 Is EGFR expression important in non-small cell lung cancer? Thorax 61 98 99 1:STN:280:DC%2BD28%2FmtVWisQ%3D%3D 10.1136/thx.2005.047936 16443704 (Pubitemid 43235423)
6. AD Sihoe AP Yim 2004 Lung cancer staging J Surg Res 117 92 106 10.1016/j.jss.2003.11.006 15013719 (Pubitemid 38317214)
7. T Naruke T Goya R Tsuchiya K Suemasu 1988 Prognosis and survival in resected lung carcinoma based on the new international staging system J Thorac Cardiovasc Surg 96 440 447 1:STN:280:DyaL1czhslKltQ%3D%3D 2842549
8. V Rigau TJ Molina C Chaffaud G Huchon J Audouin S Chevret JM Bréchot 2002 Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence Lung Cancer 38 169 176 1:STN:280:DC%2BD38nktVegtA%3D%3D 10.1016/S0169-5002(02)00213-1 12399129 (Pubitemid 35154382)
9. I Takanami 2006 Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer Oncol Rep 15 437 442 16391866
10. WD Travis LB Travis SS Devesa 1995 Lung Cancer Cancer 75 191 202 1:STN:280:DyaK2M%2FpsVWhsw%3D%3D 10.1002/1097-0142(19950101)75:1+<191::AID- CNCR2820751307>3.0.CO;2-Y 8000996
11. S Khayyata S Yun T Pasha B Jian C McGrath G Yu P Gupta Z Baloch 2009 Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens Diagn Cytopathol 37 178 183 10.1002/dc.20975 19170169
12. V Monica P Ceppi L Righi V Tavaglione M Volante G Pelosi GV Scagliotti M Papotti 2009 Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung Mod Pathol 22 709 717 1:CAS:528:DC%2BD1MXlt1SltL0%3D 10.1038/modpathol.2009.30 19287461
13. A Marks DR Sutherland D Bailey J Iglesias J Law M Lei H Yeger D Banerjee R Baumal 1999 Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours Br J Cancer 80 569 578 1:CAS:528:DyaK1MXjtFyks7w%3D 10.1038/sj.bjc.6690393 10408868 (Pubitemid 29213215)
14. D Bailey A Marks M Stratis R Baumal 1991 Immunohistochemical staining of germ cell tumors and intratubular malignant germ cells of the testis using antibody to placental alkaline phosphatase and a monoclonal anti-seminoma antibody Mod Pathol 4 167 171 1:STN:280:DyaK3M3mtFymuw%3D%3D 1646453
15. HJ Kahn D Bailey A Marks 2002 Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas Mod Pathol 15 434 440 10.1038/modpathol.3880543 11950918 (Pubitemid 34326952)
16. S Breiteneder-Geleff A Soleiman H Kowalski R Horvat G Amann E Kriehuber K Diem W Weninger E Tschachler K Alitalo D Kerjaschki 1999 Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium Am J Pathol 154 385 394 1:STN:280:DyaK1M7kvFKnsQ%3D%3D 10.1016/S0002-9440(10)65285-6 10027397 (Pubitemid 29094089)
17. L Browning D Bailey A Parker 2008 D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma J Clin Pathol 61 293 296 1:STN:280:DC%2BD1c7ksVShug%3D%3D 10.1136/jcp.2007.049544 17660332 (Pubitemid 351354232)
18. AY Chu LA Litzky TL Pasha G Acs PJ Zhang 2005 Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma Mod Pathol 18 105 110 1:CAS:528:DC%2BD2MXivVWh 10.1038/modpathol.3800259 15389250 (Pubitemid 40128102)
19. NG Ordóñez 2005 D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma Hum Pathol 36 372 380 10.1016/j.humpath.2005.01.019 15891998 (Pubitemid 40591807)
20. HJ Kahn A Marks 2002 A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors Lab Invest 82 1255 1257 12218087 (Pubitemid 35014860)
21. KL Dumoff C Chu X Xu T Pasha PJ Zhang G Acs 2005 Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix Mod Pathol 18 97 104 1:CAS:528:DC%2BD2MXivVan 10.1038/modpathol.3800269 15467716 (Pubitemid 40128101)
22. K Schmid P Birner V Gravenhorst A End S Geleff 2005 Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung Am J Surg Pathol 29 324 328 10.1097/01.pas.0000149706.74216.b6 15725800 (Pubitemid 40321967)
23. E Sinzelle JP Duong Van Huyen S Breiteneder-Geleff E Braunberger A Deloche D Kerjaschki P Bruneval 2000 Intrapericardial lymphangioma with podoplanin immunohistochemical characterization of lymphatic endothelial cells Histopathology 37 93 94 1:STN:280:DC%2BD3cvgsVWquw%3D%3D 10.1046/j.1365-2559. 2000.00955-8.x 10931742 (Pubitemid 30496746)
24. RE Nisato JC Tille MS Pepper 2003 Lymphangiogenesis and tumor metastasis Thromb Haemost 90 591 597 1:CAS:528:DC%2BD3sXot1ynu70%3D 14515178 (Pubitemid 37287626)
25. F Renyi-Vamos J Tovari J Fillinger J Timar S Paku I Kenessey G Ostoros L Agocs I Soltesz B Dome 2005 Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer Clin Cancer Res 11 7344 7353 1:CAS:528:DC%2BD2MXhtFartbrP 10.1158/1078-0432.CCR-05-1077 16243806 (Pubitemid 41507693)
26. Y Adachi H Nakamura Y Kitamura Y Taniguchi K Araki K Shomori Y Horie Y Kurozawa H Ito K Hayashi 2007 Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases Pathol Int 57 171 177 1:CAS:528:DC%2BD2sXksVCqt7c%3D 10.1111/j.1440-1827.2007.02077.x 17316411 (Pubitemid 46279944)
27. S Iwakiri S Nagai H Katakura K Takenaka H Date H Wada F Tanaka 2009 D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung Ann Surg Oncol 16 1678 1685 10.1245/s10434-009-0432-6 19330380
28. L Faoro JY Hutto R Salgia SA El-Zayaty MK Ferguson RT Cheney ME Reid SG Armato III T Krausz AN Husain 2008 Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma Arch Pathol Lab Med 132 1882 1888 19061284
29. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E (1999) World health organization pathology panel: world health organization. Histological typing of lung and pleural tumors. International histological classification of tumors, 3rd edn. Springer, Berlin, pp 9-124
30. Greene F, Page D, Fleming I et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York, pp 167-182
31. SA Sarkis BH Abdullah BA Abdul Majeed NG Talabani 2010 Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis Head Neck Oncol 2 13 10.1186/1758-3284-2-13 20579333
32. MI Koukourakis A Giatromanolaki E Sivridis C Simopoulos KC Gatter AL Harris DG Jackson 2005 LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer J Clin Pathol 58 202 206 1:STN:280:DC%2BD2M%2FltVWitA%3D%3D 10.1136/jcp.2004.019174 15677543 (Pubitemid 40193808)
33. NG Ordóñez 2006 The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study Mod Pathol 19 417 428 10.1038/modpathol.3800544 16415794 (Pubitemid 43276996)
34. N Kimura I Kimura 2005 Podoplanin as a marker for mesothelioma Pathol Int 55 83 86 1:CAS:528:DC%2BD2MXivVymurk%3D 10.1111/j.1440-1827.2005.01791.x 15693854 (Pubitemid 40343728)
35. YK Hong N Harvey YH Noh V Schacht S Hirakawa M Detmar G Oliver 2002 Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate Dev Dyn 225 351 357 1:CAS:528:DC%2BD38XptVGgsro%3D 10.1002/dvdy.10163 12412020 (Pubitemid 35265813)
36. V Schacht MI Ramirez YK Hong S Hirakawa D Feng N Harvey M Williams AM Dvorak HF Dvorak G Oliver M Detmar 2003 T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema EMBO J 22 3546 3556 1:CAS:528:DC%2BD3sXlsl2lur4%3D 10.1093/emboj/cdg342 12853470 (Pubitemid 36898332)
37. V Schacht SS Dadras LA Johnson DG Jackson YK Hong M Detmar 2005 Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors Am J Pathol 166 913 921 1:CAS:528:DC%2BD2MXivVOmsbk%3D 10.1016/S0002-9440(10)62311-5 15743802 (Pubitemid 40315647)
38. A Gandarillas FG Scholl N Benito C Gamallo M Quintanilla 1997 Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis Mol Carcinog 20 10 18 1:CAS:528:DyaK2sXms1SmtL4%3D 10.1002/(SICI)1098-2744(199709)20:1<10::AID- MC3>3.0.CO;2-M 9328432 (Pubitemid 27461534)
39. R Clarijs DJ Ruiter RM de Waal 2001 Lymphangiogenesis in malignant tumours: does it occur? J Pathol 193 143 146 1:CAS:528:DC%2BD3MXhtFGqtLg%3D 10.1002/path.808 11180158 (Pubitemid 32118123)
40. MS Pepper 2001 Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 7 462 468 1:CAS:528:DC%2BD3MXjtVOgtbw%3D 11297234 (Pubitemid 32707965)